Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Aisling Capital
New YorkSeed–Series C
12 people
Advent Life Sciences
LondonSeed–Series C
28 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
38 people
Two Sigma Ventures
New YorkSeed–Series B$2M – $15M
26 people
ATEL Ventures
San FranciscoSeed–Late Stage
15 people
Shunwei Capital
BeijingSeed–Growth
25 people
SR One Capital Management
Redwood CitySeed–Series B
30 people
OMERS Ventures
TorontoPre-Seed–Series C$5M – $25M
15 people
Medicxi
LondonSeed–Series B
38 people
LG Technology Ventures
Silicon ValleySeed–Growth
23 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Hitachi Ventures
MunichSeed–Growth
32 people
Legend Capital
BeijingSeed–Series C$2M – $10M
28 people
Vensana Capital
MinneapolisSeries A–Late Stage
43 people
GreatPoint Ventures
San FranciscoSeed–Series B$250K – $20M
15 people
Supernova Invest
ParisSeed–Growth
34 people
AME Cloud Ventures
Palo AltoSeed–Late Stage$1M – $10M
11 people
Kibo Ventures
MadridSeed–Series B$2.2M – $5.4M
31 people
Sandbox Industries
ChicagoSeed–Growth
34 people
Investinor
TrondheimPre-Seed–Growth
43 people
RiverVest Venture Partners
St. LouisSeed–Series C$500K – $3M
23 people
Schmidt
SeoulSeed–Growth
11 people
Droia Ventures
LuxembourgSeed–Series B$540K
40 people
Capricorn Venture Partners
LeuvenSeed–Growth$270K – $10.8M
29 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.













































































































